BSD Medical to collaborate wtih General Electric on new MRI-Monitored cancer treatment system





BSD Medical Corporation announced that the company has agreed to collaborate with GE Medical Systems in the integration of BSD Medical’s premier cancer treatment system with a GE magnetic resonance imaging (MRI) system.

BSD Medical Corporation announced that the company has agreed to collaborate with GE Medical Systems in the integration of BSD Medical’s premier cancer treatment system with a GE magnetic resonance imaging (MRI) system. The new system to be installed at Duke University will provide MRI monitoring of cancer treatments in progress as delivered by a BSD Medical system. The will be the first collaborative engineering effort between GE and BSD Medical, although BSD Medical has worked with Siemens Medical Systems in prior integrations for MRI monitoring of cancer treatments with BSD Medical’s systems.

The BSD-2000/3D/MR is a hybrid integration of a BSD-2000/3D cancer treatment system with a magnetic resonance imaging system (MRI) used to visually monitor deep thermal therapy cancer treatments in progress with thermal imaging through MR-tomography. The images are in color, and temperature within the images is differentiated visually by use of color coding. MR-tomography is therefore a classical application for monitoring cancer treatments with BSD Medical’s systems, as these treatments involve delivery of precision-focused heat through RF/microwave energy.